Showing results (1801-1810 of 1,979) with videos related to
Sort By:
Pageof 198
International Journal of Systematic and Evolutionary Microbiology|April 16, 2015
Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sourcesBirgit De Smet, Mark Mayo, Charlotte Peeters, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Targeting tumor vasculature with an oncolytic virusCaroline J Breitbach, Naomi S De Silva, Theresa J Falls, et al.American Journal of Hematology|September 29, 2011
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodesCarlton D Dampier, Wally R Smith, Hae-Young Kim, et al.Cancer Immunology Research|February 5, 2017
NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular VaccineAlmohanad A Alkayyal, Lee-Hwa Tai, Michael A Kennedy, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacyJeong Heo, Caroline J Breitbach, Anne Moon, et al.Cancer Research|February 9, 2013
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humansCaroline J Breitbach, Rozanne Arulanandam, Naomi De Silva, et al.Calcified Tissue International|May 16, 2001
Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcomaA B Sparks, S N Peterson, C Bell, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeuticJulia L Rintoul, Chantal G Lemay, Lee-Hwa Tai, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2010
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizersJean-Simon Diallo, Fabrice Le Boeuf, Frances Lai, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2020
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisRebecca Cosgriff, Susannah Ahern, Scott C Bell, et al.Pageof 198